Immunovant Inc (IMVT)

NASDAQ
4.17
+0.17(+4.25%)
After Hours
4.05
-0.12(-2.88%)
- Real-time Data
  • Volume:
    911,147
  • Day's Range:
    3.98 - 4.25
  • 52 wk Range:
    3.14 - 11.60

IMVT Overview

Prev. Close
4
Day's Range
3.98-4.25
Revenue
-
Open
4.05
52 wk Range
3.14-11.6
EPS
-1.42
Volume
911,147
Market Cap
485.83M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
382,820
P/E Ratio
-
Beta
-
1-Year Change
-62.09%
Shares Outstanding
116,505,412
Next Earnings Date
07 Aug 2022
What is your sentiment on Immunovant?
or
Market is currently closed. Voting is open during market hours.

Immunovant Inc Analysis

Immunovant Inc Company Profile

Immunovant Inc Company Profile

Employees
68

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyNeutralStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyBuyStrong Sell
  • Yess Green back. Bullish thanks you
    0